US Patient Groups Give Thumbs-Up to Rule Against Surprise Billing
The National Organization for Rare Disorders (NORD) is applauding the Biden administration for announcing a rule to protect…
Bionews, the owner and publisher of this site, employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, who ensure stories are well-written and easy to understand. Our stories undergo a comprehensive fact-checking and editing process to confirm accuracy, objectiveness, and thoroughness in order to best serve our audience of patients and caregivers.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
The National Organization for Rare Disorders (NORD) is applauding the Biden administration for announcing a rule to protect…
AllianceRx Walgreens Prime, a specialty and home delivery pharmacy, is partnering with TailorMed, a healthcare technology company, to help lower…
Nominations are now open for the worldwide 2022 Black Pearl Awards from Eurordis-Rare Diseases Europe. The 12 award…
SMA News Today is conducting a U.S.-based survey to better understand the characteristics, needs, and treatment experiences of the…
A recent survey showed that spinal muscular atrophy (SMA) patients and their families are generally supportive of genetic screening program…
On the eve of the weekend Christmas holiday, the U.S. Food and Drug Administration (FDA) approved Biogen’s therapy Spinraza (nusinersen) for the…
Get regular updates to your inbox.